Guanidinoacetate methyltransferase deficiency

Guanidinoacetate methyltransferase deficiency (GAMT) severely affects the brain and muscles. Most people with GAMT have serious neurological problems, including intellectual disability, problems with speech development, seizures, autistic behaviors, weak muscle tone and delayed development of motor skills such as sitting or walking. Early treatment and diagnosis can help improve some symptoms of the condition.

Quick facts about Guanidinoacetate methyltransferase deficiency
Genes: GAMT
Inheritance: Autosomal Recessive
Alternative Names: GAMT
Relevant resources for Guanidinoacetate methyltransferase deficiency

A quick genetics rundown

As humans we have about 23,000 genes. These genes are like tiny instruction manuals that influence our health, growth and development. We inherit half of our genes from our biological mum and the other half from our biological dad. These genes are lined up on structures called chromosomes. Most of us have 23 pairs of chromosomes. The first 22 pairs are called autosomes and for the most part - these are the same among men and women. The 23rd pair determine our sex - two X chromosomes for a female and one X and one Y chromosome for males.

Learn more about genetics

How is Guanidinoacetate methyltransferase deficiency inherited?

Guanidinoacetate methyltransferase deficiency is known as an autosomal recessive condition. For autosomal recessive conditions, if a person has a variation in one copy of their gene, they are a carrier. This means that they are healthy because they also have a working copy of the gene. But, they can still pass their non-working copy to their child.

If the other parent also happens to be a carrier of the same gene, there is a 25% (1 in 4) chance that they both pass this gene variation on to their child — and as such, have a child affected by the disease.

If both parents are carriers of Guanidinoacetate methyltransferase deficiency, there’s a one in four chance that their children could develop symptoms.
Learn more about carrier screening

What is carrier screening?

Carrier testing is like a checkup for your genes. It tests to see if you carry a gene variation that could cause a serious genetic disease in your child. Eugene offers an inclusive genetic carrier screening panel that includes Guanidinoacetate methyltransferase deficiency, but there's a total 301 conditions that can be tested.

Eugene’s carrier test is a clinical grade test that can be done from the comfort of your own home — it’s just a saliva test. You're also paired with a genetic counsellor who provides mindful support and guidance every step of the way.

Learn more about carrier screening

Should parents screen for Guanidinoacetate methyltransferase deficiency before or early in pregnancy?

The biggest benefit of screening for Guanidinoacetate methyltransferase deficiency is that it can help future parents understand their reproductive risk so they can be ready and empowered to make more informed decisions. If neither partner are carriers, it provides reassurance and peace of mind that the risk of having a child with a genetic disease is low.

Since 90% of children that have a recessive genetic disease like Guanidinoacetate methyltransferase deficiency had no previous family history of it, it often feels completely out of the blue for the parents. Getting screened is a way to know this risk in advance, which can help familes manage or even prevent the disease in the first place.

Wondering if this test is right for you?

Take a two minute quiz to find out.